Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Banks, energy stocks weigh on European bourses; BMW tumbles

by Uma Rajagopal
0 comments
2024 09 10T073156Z 1 LYNXMPEK8907R RTROPTP 4 EUROPE STOCKS

 

By Pranav Kashyap and Lisa Pauline Mattackal

(Reuters) -European equity markets largely lost ground on Tuesday, weighed by bank and energy stocks as investors tread cautiously ahead of key U.S. inflation data and an anticipated European Central Bank rate cut later in the week.

Shares of automaker BMW slumped 11%, notching their worst day in over four years after the company cut its 2024 profit margin outlook due to sluggish demand in its key Chinese market and problems related to a braking system supplied by Continental.

Continental shares dropped 10.5%.

“With China only getting tougher and BMW overexposed to China, and with H2 recovery expectations looking a bit optimistic, it remains tough to see the positive catalyst for BMW,” Citi analysts wrote in a note.

Bank stocks also fell sharply, tracking a selloff in U.S. lenders with analysts citing downbeat comments from Goldman Sachs CEO David Solomon.

Deustche Bank >DBKGn.DE> dropped 4.91%, and a European index tracking bank stocks lost 1.6%.

The oil and gas sector also fell 1.6% as Brent crude prices slipped below $70 per barrel for the first time since December 2021.

The pan-European STOXX 600 index fell 0.5%, reversing gains from earlier in the day, with the automobile sector down 3.8% and German stocks falling nearly 1%.

Markets were uneasy ahead of Wednesday’s U.S. inflation report, which could provide clarity on the size of the Federal Reserve’s rate cut when it meets next week.

The path for interest rates and economic growth in the world’s largest economy has largely set the tone for global markets over the past months.

In Europe, the ECB meets on Thursday and markets have fully priced in a 25 basis-point rate cut, though the policy path for the rest of this year remains more uncertain.

“The question for markets is what happens next,” analysts at ING said.

“(The ECB) downplaying the chance of an October cut and confining itself to quarterly steps on rates – at least for now – should act as a brake on the potential pace of easing.”

The rate-sensitive real estate sector was one of the few gainers on the STOXX 600 index, rising 1.7%.

On the economic front, data showed German inflation slowed to 2% in August.

Among individual movers, Commerzbank closed down 2.4% as the German government began to sell some of its shares, as previously announced. CEO Manfred Knof also said he would not seek another term after his contract ends in 2025.

Heavy-weight AstraZeneca shed 2.4% after detailed study results showed its experimental lung cancer drug did not significantly improve patients’ overall survival results.

(Reporting by Pranav Kashyap and Lisa Mattackal in Bengaluru; Editing by Eileen Soreng and Emelia Sithole-Matarise)